Literature DB >> 1560188

Epidermal growth factor receptor in human brain tumors.

A Di Carlo1, A Mariano, P E Macchia, M C Moroni, L Beguinot, V Macchia.   

Abstract

The expression of epidermal growth factor receptor (EGF-R) was examined in 27 primary human brain tumors (7 glioblastomas, 10 astrocytomas, 5 oligodendrogliomas, 1 schwannoma, 1 ganglioneuroma, 1 medulloblastoma, 1 ependymoma, 1 histiocytic lymphoma), in 6 brain metastases from lung carcinomas and in 20 meningiomas. Peritumoral tissues histologically normal excised surgically along with a large tumor were used as control. All plasma membranes from brain tissues tested showed specific EGF binding. The EGF receptor is expressed at low levels in the control human brain and at very high levels in 60% of the total intracranial tumors studied. When the various histological types of tumors were analyzed, the higher percentage of positive tumors was found with the meningiomas (85%) and the glioblastomas (71%), while the lower percentage of positivity was found with the oligodendrogliomas (40%) and the astrocytomas (30%). A good correlation between binding and total amount of EGF-R protein detected by Western Blot was also observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560188     DOI: 10.1007/BF03348650

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.

Authors:  M Yao; T Shuin; H Misaki; Y Kubota
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

2.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

3.  Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture.

Authors:  N Kamata; K Chida; K Rikimaru; M Horikoshi; S Enomoto; T Kuroki
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

4.  Retroviruses expressing different levels of the normal epidermal growth factor receptor: biological properties and new bioassay.

Authors:  T J Velu; L Beguinot; W C Vass; K Zhang; I Pastan; D R Lowy
Journal:  J Cell Biochem       Date:  1989-02       Impact factor: 4.429

5.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

6.  Functional studies on the EGF receptor with an antibody that recognizes the intracellular portion of the receptor.

Authors:  L Beguinot; D Werth; S Ito; N Richert; M C Willingham; I Pastan
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

7.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

8.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Authors:  T J Velu; L Beguinot; W C Vass; M C Willingham; G T Merlino; I Pastan; D R Lowy
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

9.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

10.  Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

Authors:  S Nicholson; J R Sainsbury; G K Needham; P Chambers; J R Farndon; A L Harris
Journal:  Int J Cancer       Date:  1988-07-15       Impact factor: 7.396

View more
  6 in total

1.  Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma.

Authors:  A Gabriella Wernicke; Adam P Dicker; Michal Whiton; Jana Ivanidze; Terry Hyslop; Elizabeth H Hammond; Arie Perry; David W Andrews; Lawrence Kenyon
Journal:  Radiat Oncol       Date:  2010-05-30       Impact factor: 3.481

2.  Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.

Authors:  M E Berens; M D Rief; J R Shapiro; D Haskett; A Giese; A Joy; S W Coons
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

3.  Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.

Authors:  E Schröck; G Thiel; T Lozanova; S du Manoir; M C Meffert; A Jauch; M R Speicher; P Nürnberg; S Vogel; W Jänisch
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

4.  Epidermal growth factor receptor and lipid membrane components in human lung cancers.

Authors:  A Di Carlo; A Mariano; P E Macchia; C Cecere; G Ferrante; V Macchia
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

5.  Expression and function of water channels (aquaporins) in migrating malignant astrocytes.

Authors:  Eric McCoy; Harald Sontheimer
Journal:  Glia       Date:  2007-08-01       Impact factor: 7.452

6.  Expression and clinical value of EGFR in human meningiomas.

Authors:  Magnus B Arnli; Thomas Backer-Grøndahl; Borgny Ytterhus; Unn S Granli; Stian Lydersen; Sasha Gulati; Sverre H Torp
Journal:  PeerJ       Date:  2017-03-29       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.